Skip to content
HomeLatest newsMicrobiome researcher Jeffrey Gordon receives the 2022 Dr. Paul Janssen Award for biomedical research
A headshot of Jeffrey Gordon, M.D.

Microbiome researcher Jeffrey Gordon receives the 2022 Dr. Paul Janssen Award for biomedical research

Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.

Share Article
share to
The Dr. Paul Janssen Award for Biomedical Research

Jeffrey Gordon, M.D., a Distinguished University Professor at Washington University in St. Louis, has been awarded the 2022 Dr. Paul Janssen Award for Biomedical Research. The annual honor goes to a scientist who has made a transformational contribution toward improving human health. Dr. Gordon’s work clearly embodies the spirit of the award.

Innovating to Change the Trajectory of Health

Known as the “father of microbiome research,” Dr. Gordon has changed our understanding of how human physiology is shaped by our microbial communities, provided a more nuanced view of what’s known as germ theory and expanded our understanding of microbial contributions to noncommunicable diseases.

He’s also ushered in a new era of microbiome-based therapeutics and preventive medicine. Case in point: His discovery of gut microbiome-directed therapeutic foods represents a new approach to treating childhood malnutrition—the leading cause of death in children 5 and under across the globe.
The Dr. Paul Janssen Award was established in 2004 by what is now called the Janssen Pharmaceutical Companies of Johnson & Johnson to honor the memory of “Dr. Paul,” who coined over 100 patents and developed dozens of life-changing medications. Since its inception, the award has recognized 19 scientists, five of whom have gone on to win the Nobel Prize for the same work. The award includes a $200,000 cash prize.

To hear from Dr. Gordon directly and learn more about the impact of his work, watch the video below.

poster.jpg

Meet more Dr. Paul Janssen Award winners

See how past awardees have left a lasting legacy with their own scientific breakthroughs.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.